Pharmaceutical Executive Editorial Staff from Pharmaceutical Executive - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare		FDA Grants Priority Review to Genentech's sBLA for Xolair to Treat Food Allergies - 5 months ago FDA Approves Filsuvez for Epidermolysis Bullosa - 5 months ago FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema - 5 months ago Merck's 21-Valent Pneumococcal Conjugate Vaccine Granted FDA Priority Review - 5 months ago FDA Approves Expanded Indication for LEO Pharma's Adbry for Pediatric Patients With Atopic Dermatitis - 5 months ago Moderna's Novel mRNA Vaccine Shows Significant Efficacy Against RSV - 5 months ago GSK's Jemperli Plus Zejula Produces Significant Survival Improvement in Endometrial Cancer - 5 months ago Arcutis Biotherapeutics, Inc’s Zoryve Gets FDA Approval for Seborrheic Dermatitis - 5 months ago FDA Approves Padcev/Keytruda Combo for Locally Advanced, Metastatic Urothelial Cancer - 5 months ago Erasca’s Naporafenib Gets FDA Fast Track Designation for Metastatic Melanoma - 5 months ago Moderna and Merck's Novel Cancer Vaccine, Keytruda Combo Cuts Risk of Skin Cancer Death, Recurrence by Half - 5 months ago CDC Raises Urgent Alert for Low Vaccination Coverage for COVID-19, Influenza, RSV - 5 months ago FDA Approves Merck's Welireg for Advanced Renal Cell Carcinoma - 5 months ago FDA Approves First Treatment Indicated to Lower Risk of Relapse in Pediatric Patients With High-Risk Neuroblastoma - 5 months ago Pfizer Clears Final Regulatory Hurdles to Acquire Seagen Inc - 5 months ago MAPS Seeks Approval of First Psychedelic-Assisted Therapy for PTSD - 5 months ago AstraZeneca Strengthens Respiratory Illness Pipeline With Acquisition of Icosavax - 5 months ago Bristol Myers Squibb to Pay Up to $8.4 Billion to Codevelop Antibody-Drug Conjugate With SystImmune - 5 months ago Merck and Moderna to Launch Trial of mRNA-4157 Plus Keytruda in Non-Small Cell Lung Cancer - 5 months ago FDA Expands Indication of Cresemba for Use in Children With Invasive Aspergillosis, Invasive Mucormycosis - 5 months ago FDA Approves Two Landmark Cell-Based Gene Therapies for Sickle Cell Disease - 5 months ago Prevalence of Eight Chronic Health Conditions Reach Unprecedented Levels in US - 6 months ago Teva's Ajovy Shows Similar Efficacy Reducing Migraine Attacks in Patients With Obesity - 6 months ago Merck Halts Phase 3 Trial of Keytruda Combination for Non-Small Cell Lung Cancer - 6 months ago Merck Halts Phase III Trial of Keytruda Combination for Non-Small Cell Lung Cancer - 6 months ago CVS Becomes Latest PBM to Overhaul Drug Pricing Formula - 6 months ago FDA Approves Novartis’ Fabhalta for Paroxysmal Nocturnal Hemoglobinuria - 6 months ago Eli Lilly Announces Availability of Obesity Drug Zepbound at US Pharmacies - 6 months ago FDA Grants Breakthrough Designation to Johnson & Johnson’s Novel Treatment for HR-NMIBC - 6 months ago FDA Grants Priority Review to Bristol Myers Squibb's Opdivo Combination for Urothelial Carcinoma - 6 months ago Roche Bolsters Obesity, Diabetes R&D Portfolio With Acquisition of Carmot Therapeutics - 6 months ago FDA Approves Lilly's Jaypirca for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma - 6 months ago FDA Grants Priority Review to Keytruda Plus Padcev for Urothelial Carcinoma - 6 months ago FDA Fast Tracks eFFECTOR Therapeutics' Zotatifin Combo for ER+/HER2– Breast Cancer - 6 months ago AbbVie to Acquire ImmunoGen With its Platinum-Resistant Ovarian Cancer Drug Elahere - 6 months ago FDA Accepts Arcutis Biotherapeutics' sNDA for Roflumilast Cream for Atopic Dermatitis - 6 months ago FDA Issues Warning of Potential Adverse Events Associated With Antiseizure Drugs - 6 months ago FDA Accepts New Drug Application for Karuna Therapeutics' Novel Schizophrenia Drug - 6 months ago Vivos Therapeutics' Obstructive Sleep Apnea Oral Appliance Gains FDA 510(k) Clearance - 6 months ago 'High Severity' Flu Season Among Children Spotlights Importance of Vaccination - 6 months ago FDA Investigating Risk of Secondary Cancers in Patients Administered CAR T-Cell Therapy - 6 months ago Roche Announces Launch of New Tool to Improve Hepatitis B Detection - 6 months ago FDA Approves Ogsiveo to Treat Desmoid Tumors - 6 months ago Follicular Lymphoma Drug Co-Developed by AbbVie and Genmab Gets FDA Breakthrough Designation - 6 months ago Alladapt Immunotherapeutics' Oral Immunotherapy for Multiple Food Allergies Gets FDA Fast Track Designation - 6 months ago Xtandi Approved by FDA for Nonmetastatic Castration-Sensitive Prostate Cancer - 6 months ago FDA Approves Keytruda Plus Chemotherapy for Gastric, Gastroesophageal Junction Adenocarcinoma - 6 months ago FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer - 6 months ago Express Scripts to Launch New Network Option With Simpler Drug Pricing Structure - 6 months ago FDA Approves Bristol Myers Squibb’s Augtyro for Non-Small Cell Lung Cancer - 6 months ago